ProKidney Corp
PROK2.990USD
+0.170+6.03%
交易中 （美東）報價延遲15分鐘
387.31M總市值
虧損本益比TTM
關於 ProKidney Corp 公司
ProKidney Corp. 是一家臨牀階段的生物技術公司。該公司專注於細胞治療平臺，該平臺能夠使用從患者身上分離出來的細胞來治療多種慢性腎臟疾病 (CKD)。該公司的主要候選產品腎自體細胞療法 (REACT) 旨在保留 CKD 患者患病腎臟的腎功能。REACT 是一種產品，包括從患者自身（自體）腎細胞製備的自體選擇腎細胞 (SRC)。REACT 注射劑是一種研究性療法，是從參與者自身腎臟組織製備的腎細胞混合物。其專利技術包括細胞治療產品的製造和醫療輸送方面的多項突破。該公司正在針對中度至重度糖尿病腎病 (DKD) 患者開展 REACT 的全球 3 期開發計劃和多項 2 期臨牀試驗。
公司簡介
公司代碼PROK
公司名稱ProKidney Corp
上市日期Jun 30, 2021
CEODr. Bruce Culleton, M.D.
員工數量204
證券類型Ordinary Share
年結日Jun 30
公司地址2000 Frontis Plaza Blvd.
城市WINSTON-SALEM
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編27103
電話13369997028
網址https://prokidney.com/
公司代碼PROK
上市日期Jun 30, 2021
CEODr. Bruce Culleton, M.D.
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. Bruce Culleton, M.D.
Dr. Bruce Culleton, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
1.54M
--
Mr. William F. (Bill) Doyle
Mr. William F. (Bill) Doyle
Independent Director
Independent Director
--
--
Dr. Brian J. G. Pereira, M.D.
Dr. Brian J. G. Pereira, M.D.
Independent Director
Independent Director
--
--
Dr. Darin J. Weber, Ph.D.
Dr. Darin J. Weber, Ph.D.
Chief Regulatory Officer, SVP - Global Regulatory, Quality Management & Commercial
Chief Regulatory Officer, SVP - Global Regulatory, Quality Management & Commercial
--
--
Mr. James Coulston, CPA
Mr. James Coulston, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Daniel Ferry
Mr. Daniel Ferry
IR Contact Officer
IR Contact Officer
--
--
Mr. Pablo Legorreta
Mr. Pablo Legorreta
Chairman of the Board
Chairman of the Board
--
--
Mr. Todd C. Girolamo, J.D.
Mr. Todd C. Girolamo, J.D.
Chief Legal Officer
Chief Legal Officer
--
--
Mr. Lucio Tozzi
Mr. Lucio Tozzi
Senior Vice President - Global Clinical Operations
Senior Vice President - Global Clinical Operations
--
--
Dr. Uma Sinha, Ph.D.
Dr. Uma Sinha, Ph.D.
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Bruce Culleton, M.D.
Dr. Bruce Culleton, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
1.54M
--
Mr. William F. (Bill) Doyle
Mr. William F. (Bill) Doyle
Independent Director
Independent Director
--
--
Dr. Brian J. G. Pereira, M.D.
Dr. Brian J. G. Pereira, M.D.
Independent Director
Independent Director
--
--
Dr. Darin J. Weber, Ph.D.
Dr. Darin J. Weber, Ph.D.
Chief Regulatory Officer, SVP - Global Regulatory, Quality Management & Commercial
Chief Regulatory Officer, SVP - Global Regulatory, Quality Management & Commercial
--
--
Mr. James Coulston, CPA
Mr. James Coulston, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Daniel Ferry
Mr. Daniel Ferry
IR Contact Officer
IR Contact Officer
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 7月24日 週四
更新時間: 7月24日 週四
持股股東
股東類型
持股股東
持股股東
佔比
Tolerantia LLC
17.46%
Suvretta Capital Management, LLC
9.53%
Control Empresarial de Capitales, S.A. de C.V.
8.28%
Morgan Stanley Investment Management Inc. (US)
7.75%
BlackRock Institutional Trust Company, N.A.
4.88%
Other
52.10%
持股股東
持股股東
佔比
Tolerantia LLC
17.46%
Suvretta Capital Management, LLC
9.53%
Control Empresarial de Capitales, S.A. de C.V.
8.28%
Morgan Stanley Investment Management Inc. (US)
7.75%
BlackRock Institutional Trust Company, N.A.
4.88%
Other
52.10%
股東類型
持股股東
佔比
Corporation
25.74%
Investment Advisor
17.88%
Investment Advisor/Hedge Fund
12.42%
Hedge Fund
10.06%
Individual Investor
4.31%
Research Firm
0.78%
Endowment Fund
0.77%
Bank and Trust
0.09%
Pension Fund
0.03%
Other
27.93%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
186
93.75M
72.38%
-10.53M
2025Q1
188
90.99M
70.46%
-13.35M
2024Q4
184
92.39M
74.12%
+21.48M
2024Q3
176
90.75M
73.53%
+26.28M
2024Q2
216
81.85M
70.67%
+19.77M
2024Q1
231
37.73M
58.52%
-31.32M
2023Q4
239
39.92M
63.74%
-31.95M
2023Q3
236
64.28M
104.12%
-21.16M
2023Q2
223
59.02M
95.83%
-21.49M
2023Q1
183
53.54M
87.01%
-23.74M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Tolerantia LLC
22.62M
17.46%
--
--
Jun 03, 2025
Suvretta Capital Management, LLC
12.34M
9.53%
--
--
Mar 31, 2025
Control Empresarial de Capitales, S.A. de C.V.
10.72M
8.28%
+2.28M
+27.04%
Apr 22, 2025
Morgan Stanley Investment Management Inc. (US)
10.04M
7.75%
-3.51M
-25.90%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
6.32M
4.88%
+8.24K
+0.13%
Mar 31, 2025
The Vanguard Group, Inc.
5.21M
4.02%
-63.88K
-1.21%
Mar 31, 2025
BlackRock Mexico Operadora SA de CV SOFI
3.43M
2.65%
--
--
Mar 31, 2025
Palihapitiya (Chamath)
3.00M
2.32%
--
--
Nov 19, 2023
Operadora de Fondos GBM S.A.B. de C.V.
2.45M
1.89%
--
--
May 31, 2025
Geode Capital Management, L.L.C.
2.32M
1.79%
+90.34K
+4.05%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
Schwab U.S. Broad Market ETF
0%
iShares Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
iShares MSCI USA Small-Cap Min Vol Factor ETF
0%
iShares Morningstar Small-Cap ETF
0%
Strive Small-Cap ETF
0%
Global X Russell 2000 ETF
0%
iShares Russell 2000 Growth ETF
0%
Invesco Russell 2000 Dynamic Multifactor ETF
0%
Fidelity MSCI Health Care Index ETF
0%
查看更多
Schwab U.S. Broad Market ETF
佔比0%
iShares Russell 2000 ETF
佔比0%
Proshares Ultra Russell 2000
佔比0%
iShares MSCI USA Small-Cap Min Vol Factor ETF
佔比0%
iShares Morningstar Small-Cap ETF
佔比0%
Strive Small-Cap ETF
佔比0%
Global X Russell 2000 ETF
佔比0%
iShares Russell 2000 Growth ETF
佔比0%
Invesco Russell 2000 Dynamic Multifactor ETF
佔比0%
Fidelity MSCI Health Care Index ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
